Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

<p>Supplementary Figure 1. Expression of membranous NECTIN-4 in UC histology subtypes in PRIM (A) and MET (B). (C) depicts differential NECTIN-4 expression during metastatic spread. Intergroup comparison was calculated by non-parametric Kruskal-Wallis test.</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Niklas Klümper (15048887) (author)
Autres auteurs:	Damian J. Ralser (15048890) (author), Jörg Ellinger (15048893) (author), Florian Roghmann (15048896) (author), Julia Albrecht (15048899) (author), Eduard Below (15048902) (author), Abdullah Alajati (15048905) (author), Danijel Sikic (15048908) (author), Johannes Breyer (15048911) (author), Christian Bolenz (15048914) (author), Friedemann Zengerling (15048917) (author), Philipp Erben (15048920) (author), Kristina Schwamborn (15048923) (author), Ralph M. Wirtz (15048926) (author), Thomas Horn (15048929) (author), Dora Nagy (15048932) (author), Marieta Toma (15048935) (author), Glen Kristiansen (15048938) (author), Thomas Büttner (15048941) (author), Oliver Hahn (15048944) (author), Viktor Grünwald (15048947) (author), Christopher Darr (15048950) (author), Eva Erne (15048953) (author), Steffen Rausch (15048956) (author), Jens Bedke (15048959) (author), Katrin Schlack (15048962) (author), Mahmoud Abbas (15048965) (author), Stefanie Zschäbitz (15048968) (author), Constantin Schwab (15048971) (author), Alexander Mustea (15048974) (author), Patrick Adam (15048977) (author), Andreas Manseck (15048980) (author), Bernd Wullich (15048983) (author), Manuel Ritter (15048986) (author), Arndt Hartmann (15048549) (author), Jürgen Gschwend (15048989) (author), Wilko Weichert (15048992) (author), Franziska Erlmeier (15048995) (author), Michael Hölzel (15048998) (author), Markus Eckstein (14949481) (author)
Publié:	2025
Sujets:	Cancer Tumor Biology Therapeutic Research and Development Clinical Research and Trials Biological Agents & Therapies Antibody-drug conjugates Drug Resistance Clinical drug resistance Drug Targets Cell surface receptor drug targets Genitourinary Cancers Bladder cancer Precision Medicine Progression, Invasion & Metastasis Tumor progression Translational Research Tumor Heterogeneity
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

Documents similaires